Avantax Advisory Services Inc. Sells 443 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Avantax Advisory Services Inc. reduced its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 5.8% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,202 shares of the company’s stock after selling 443 shares during the quarter. Avantax Advisory Services Inc.’s holdings in GE HealthCare Technologies were worth $655,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently made changes to their positions in GEHC. Wynn Capital LLC raised its stake in GE HealthCare Technologies by 4.1% in the 1st quarter. Wynn Capital LLC now owns 3,125 shares of the company’s stock valued at $284,000 after acquiring an additional 122 shares during the period. Byrne Asset Management LLC lifted its stake in shares of GE HealthCare Technologies by 0.8% during the 1st quarter. Byrne Asset Management LLC now owns 16,424 shares of the company’s stock valued at $1,493,000 after buying an additional 126 shares in the last quarter. WASHINGTON TRUST Co boosted its holdings in GE HealthCare Technologies by 7.7% in the 1st quarter. WASHINGTON TRUST Co now owns 1,853 shares of the company’s stock worth $168,000 after buying an additional 133 shares during the period. Fiduciary Trust Co grew its stake in GE HealthCare Technologies by 1.8% in the 4th quarter. Fiduciary Trust Co now owns 7,696 shares of the company’s stock valued at $595,000 after buying an additional 133 shares in the last quarter. Finally, Quent Capital LLC raised its holdings in GE HealthCare Technologies by 21.3% during the 1st quarter. Quent Capital LLC now owns 780 shares of the company’s stock valued at $71,000 after acquiring an additional 137 shares during the period. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Table of Contents

Insiders Place Their Bets

In other news, CTO Taha Kass-Hout sold 3,300 shares of the firm’s stock in a transaction dated Tuesday, May 28th. The stock was sold at an average price of $78.70, for a total transaction of $259,710.00. Following the transaction, the chief technology officer now directly owns 67,300 shares of the company’s stock, valued at $5,296,510. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other GE HealthCare Technologies news, CEO Jan Makela sold 20,227 shares of the firm’s stock in a transaction on Monday, May 13th. The shares were sold at an average price of $81.57, for a total value of $1,649,916.39. Following the sale, the chief executive officer now owns 63,348 shares of the company’s stock, valued at approximately $5,167,296.36. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CTO Taha Kass-Hout sold 3,300 shares of the company’s stock in a transaction dated Tuesday, May 28th. The shares were sold at an average price of $78.70, for a total transaction of $259,710.00. Following the transaction, the chief technology officer now directly owns 67,300 shares of the company’s stock, valued at $5,296,510. The disclosure for this sale can be found here. Insiders sold 90,482 shares of company stock valued at $7,369,137 over the last three months. Insiders own 0.27% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the company. The Goldman Sachs Group started coverage on GE HealthCare Technologies in a research report on Thursday, May 30th. They issued a “neutral” rating and a $87.00 price target for the company. Bank of America reduced their target price on GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating for the company in a report on Wednesday, May 1st. Argus increased their price target on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a “buy” rating in a report on Monday, April 1st. Citigroup boosted their price objective on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a research note on Wednesday, April 3rd. Finally, Evercore ISI increased their target price on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a research note on Thursday, April 4th. Five analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $94.09.

Get Our Latest Stock Report on GE HealthCare Technologies

GE HealthCare Technologies Stock Down 0.6 %

GEHC opened at $80.44 on Friday. The company has a quick ratio of 0.83, a current ratio of 1.06 and a debt-to-equity ratio of 1.11. The business’s fifty day simple moving average is $78.74 and its 200 day simple moving average is $82.05. GE HealthCare Technologies Inc. has a 52 week low of $62.35 and a 52 week high of $94.50. The stock has a market cap of $36.72 billion, a PE ratio of 23.52, a P/E/G ratio of 2.89 and a beta of 1.20.

GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last released its earnings results on Tuesday, April 30th. The company reported $0.90 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.90. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. The company had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.80 billion. During the same quarter in the previous year, the company posted $0.85 EPS. GE HealthCare Technologies’s quarterly revenue was down 1.2% compared to the same quarter last year. As a group, research analysts expect that GE HealthCare Technologies Inc. will post 4.27 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be given a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a yield of 0.15%. The ex-dividend date of this dividend is Friday, July 19th. GE HealthCare Technologies’s payout ratio is presently 3.51%.

GE HealthCare Technologies Company Profile

(Free Report)

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.